Escolha sua fonte:
 Arimo
 Merriweather
 Mukta Malar
 Open Sans Condensed
 Rokkitt
 Source Sans Pro
 Login


 Português 
 Français 
 English 

[Valid RSS] RSS
bar

Banco de dados - Alliance francophone pour l'accouchement respecté (AFAR)

Descrição deste banco de dados documental (Site da AFAR)
Atualmente 3059 fichas
Canal do YouTube (tutorial)

https://afar.info/id=2792

Criado em : 26 Nov 2017
Alterado em : 26 Nov 2017

 Modificar esta ficha
Siga este link somente se você tiver um palavra chave de editor!


Compartilhar: Facebook logo   Tweeter logo   Difícil

Nota bibliográfica (sem autor) :

Comparison Between Use of Oral Misoprostol Versus Vaginal Misoprostol for Induction of Labour at Term - - p.1

Autores :

Prameela; Sharma, K.D.

Ano de publicação :

2017

URL(s) :

https://www.scopus.com/inward/record.uri?eid=2-s2.…

Résumé (français)  :

Abstract (English)  :

Background and Objective: In modern obstetrics, around 30% of cases require induction of labour for various reasons. Misoprostol is gaining popularity as pharmacological inducing agent, though the route and dosage of administration are not standardised. The objective of the study is to compare the safety and efficacy of the two routes of misoprostol administration—oral (100 μg 4th hourly) and vaginal (25 μg 4th hourly), for induction of labour at term. Methods: In this randomised trial, 104 women having crossed the expected date of delivery without going into spontaneous labour and cases which had premature rupture of membranes <12 h were considered for labour induction and were divided into two equal groups. Group A received 100 μg misoprostol orally 4th hourly, and group B received 25 μg misoprostol vaginally 4th hourly. Labour characteristics and maternal and foetal outcome were compared. Results: In terms of maternal outcome, mean number of doses for oral group is 2.73 and vaginal group is 3.04. In oral group, mean induction to vaginal delivery interval was 13 h 43 min and in vaginal group interval is 13 h 26 min which was statistically not significant. The need for oxytocin augmentation was also statistically not significant. Both groups had equal number of failed inductions. Emergency LSCS done for foetal distress was more in vaginal group 2.9% compared to oral group which is 1%, but difference was not statistically significant (p value −0.55). Number of thick MSL in oral group was 3.2% as compared to vaginal group which is 10.7% which was statistically significant (p value −0.04). APGAR score at 5 min 7/10 was seen in 7.7% in vaginal group as compared to 0% in oral group which was also statistically significant (0.004). Number of NICU admissions was also more in vaginal group compared to oral group. Conclusion: Misoprostol in either oral or vaginal route has proven to be equally effective for inducing labour in women at term pregnancy. However, occurrence of lesser incidence of meconium-stained liquor and NICU admissions and fewer caesareans with better neonatal outcome in women induced with oral misoprostol outweighs its advantages over the vaginal misoprostol. © 2017 Federation of Obstetric & Gynecological Societies of India

Sumário (português)  :

Comentários :

Argument (français) :

Argument (English):

Argumento (português):

Palavras-chaves :

➡ indução ; misoprostol (Cytotec)

Autor da esta ficha :

Import 26/11/2017 — 26 Nov 2017

Discussão (exibir apenas português)
 
➡ Reservado para usuários identificados



 Li a carta de discussões e aceito as condições (leia as diretrizes)

barre

Efectuar uma nova consulta especialista --- Outro pedido simples

Criação de uma ficha --- Importar registros

Gerenciamento de usuários --- Fazer backup do banco de dados --- Contato

bar

Esta base de dados é gerida pela Alliance francophone pour l'accouchement respecté (AFAR, https://afar.info)
filiados Collectif interassociatif autour de la naissance (CIANE, https://ciane.net).
Ele é alimentado pelas contribuições de voluntários interessados ​​em compartilhar informações científicas.
Se você aprovar este projeto, você pode nos ajudar de várias maneiras:
(1) tornar-se um colaborador com base nisso, se você tem um pouco experiência na literatura científica
(2) ou apoio financeiro AFAR (veja abaixo)
(3) ou tornar-se um membro da AFAR (ou outra associação afiliada à CIANE).
Faça login ou crie uma conta para seguir as alterações ou se tornar um editor.
Contato afar.association(arobase)gmail.com para mais informações.

Valid CSS! Valid HTML!
Doar para a AFAR (clique em “Faire un don”) nos ajudará a manter e desenvolver sites e bancos de dados
públicos para o apoio das decisões informadas dos pais e cuidadores com relação ao parto